New hope for pancreatic cancer: targeted drug combo enters human trials

NCT ID NCT07377045

First seen Feb 01, 2026 · Last updated Apr 24, 2026 · Updated 15 times

Summary

This early-phase trial tests a new drug, OMTX705, that targets a protein found on cancer-supporting cells. It is given together with standard chemotherapy and an immunotherapy drug for people with advanced or metastatic pancreatic cancer. The study aims to find the safest dose and see if the combination helps shrink tumors or slow the disease.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PANCREATIC ADENOCARCINOMA METASTATIC are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Beth Israel Deaconess Medical Center (BIDMC)

    NOT_YET_RECRUITING

    Boston, Massachusetts, 02215, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Clinica Universidad de Navarra (CUN)

    RECRUITING

    Pamplona, 31008, Spain

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Hospital Clínico Universitario de Santiago - CHUS

    NOT_YET_RECRUITING

    Santiago de Compostela, 15706, Spain

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Hospital Universitario 12 Octubre

    RECRUITING

    Madrid, 28041, Spain

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Hospital Universitario Donostia

    NOT_YET_RECRUITING

    Donostia / San Sebastian, 20014, Spain

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Hospital Universitario Vall d'Hebron (VHIO)

    NOT_YET_RECRUITING

    Barcelona, 08035, Spain

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • ICO- Hospitalet Catalan Institute of Oncology

    RECRUITING

    L'Hospitalet de Llobregat, 08908, Spain

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.